Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03729700 · ClinicalTrials.gov registry record · NA

The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT03729700: Completed NA study, sponsored by University of California, Davis.

NCT03729700 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03729700, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The investigator hypothesizes that regular consumption of almonds will 1) improve the facial wrinkle severity in post-menopausal women, 2) improve the evenness of facial skin pigmentation, 3) diversify the gut microbiome and increase the short chain fatty acids in the blood, and 4) improve the skin barrier biophysical properties.

Primary Outcome

Photographs will be obtained at baseline, 8 weeks, 16 weeks, and 24 weeks. The images will be obtained with the 3D Clarity Pro® Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA) that has standardized positioning and lighting and iPad. The investigator has already validated this measurement tool against standard clinical grading of facial wrinkles.

Interventions

  • OTHER Almond

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-10-22
Est. Completion 2021-06-22
Phase NA
University of California, Davis

657 total trials

What the finished NCT03729700 record still lists

NCT03729700 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Almond is the first listed.

NCT03729700 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03729700 about?

NCT03729700 is a clinical study titled "The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome". The investigator hypothesizes that regular consumption of almonds will 1) improve the facial wrinkle severity in post-menopausal women, 2) improve the evenness of facial skin pigmentation, 3) diversify the gut microbiome and increase the short chain fatty acids in the blood, and 4) improve the skin ...

What is the current status of trial NCT03729700?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-10-22. Estimated completion is 2021-06-22.

What interventions are being tested in trial NCT03729700?

The interventions under investigation include: Almond (OTHER).

Who is sponsoring clinical trial NCT03729700?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03729700's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03729700, the US trial registry maintained by the National Library of Medicine. NCT03729700 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.